Labcorp Holdings, Inc. (LH)
308.49
+3.89
(+1.28%)
USD |
NYSE |
Oct 02, 16:00
308.50
+0.01
(+0.00%)
Pre-Market: 20:00
Labcorp Holdings Enterprise Value : 31.60B for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 31.60B |
| October 01, 2026 | 31.28B |
| September 30, 2026 | 31.57B |
| September 29, 2026 | 31.62B |
| September 28, 2026 | 31.68B |
| September 25, 2026 | 31.69B |
| September 24, 2026 | 31.63B |
| September 23, 2026 | 31.23B |
| September 22, 2026 | 31.84B |
| September 21, 2026 | 32.61B |
| September 18, 2026 | 32.59B |
| September 17, 2026 | 32.75B |
| September 16, 2026 | 32.89B |
| September 15, 2026 | 32.85B |
| September 14, 2026 | 32.15B |
| September 11, 2026 | 31.84B |
| September 10, 2026 | 31.47B |
| September 09, 2026 | 32.62B |
| September 08, 2026 | 32.92B |
| September 04, 2026 | 33.09B |
| September 03, 2026 | 33.46B |
| September 02, 2026 | 33.47B |
| September 01, 2026 | 33.14B |
| August 31, 2026 | 33.55B |
| August 28, 2026 | 33.75B |
| Date | Value |
|---|---|
| August 27, 2026 | 33.87B |
| August 26, 2026 | 33.80B |
| August 25, 2026 | 33.96B |
| August 24, 2026 | 34.09B |
| August 21, 2026 | 33.85B |
| August 20, 2026 | 33.57B |
| August 19, 2026 | 33.37B |
| August 18, 2026 | 32.71B |
| August 17, 2026 | 32.80B |
| August 14, 2026 | 32.38B |
| August 13, 2026 | 32.74B |
| August 12, 2026 | 32.81B |
| August 11, 2026 | 32.72B |
| August 10, 2026 | 32.63B |
| August 07, 2026 | 32.46B |
| August 06, 2026 | 32.25B |
| August 05, 2026 | 32.04B |
| August 04, 2026 | 31.91B |
| August 03, 2026 | 31.51B |
| July 31, 2026 | 31.65B |
| July 30, 2026 | 32.17B |
| July 29, 2026 | 31.49B |
| July 28, 2026 | 32.06B |
| July 27, 2026 | 31.01B |
| July 24, 2026 | 30.65B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Quest Diagnostics, Inc. | 31.81B |
| DaVita, Inc. | 24.97B |
| CVS Health Corp. | 173.04B |
| OPKO Health, Inc. | 1.261B |
| Psychemedics Corp. | -- |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 299.10M |
| Revenue (Quarterly) | 3.731B |
| Total Expenses (Quarterly) | 3.432B |
| EPS Diluted (Quarterly) | 3.643 |
| Gross Profit Margin (Quarterly) | 27.71% |
| Profit Margin (Quarterly) | 8.02% |
| Earnings Yield | 3.92% |
| Operating Earnings Yield | 6.37% |
| Normalized Earnings Yield | 4.282 |